SCHEMBL3770141

SCHEMBL3770141

COC(=O)C1C2CCC(CC2)C1CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
MMP13 P45452 1/20 0.42
MAPT P10636 2/20 0.41
PLIN1 O60240 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
PLIN5 Q00G26 1/20 0.41
ABHD5 Q8WTS1 1/20 0.41
SLC6A3 Q01959 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770265 0.94 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL3779414 0.83 MMP2 (0.54) CYP1A2CYP2C9CYP2C19MMP1MMP2
SCHEMBL3783014 0.82 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL3772347 0.81 SLC6A4 (0.47) CYP1A2CYP2C9CYP2C19SLC6A3
SCHEMBL3781291 0.80 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1MAPTPLIN1
SCHEMBL3785359 0.79 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL3777053 0.77 ALDH1A1 (0.39) ALDH1A1MAPTPLIN1HPGDALOX15
SCHEMBL3787457 0.77 MMP2 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL3784242 0.77 MMP2 (0.50) CYP1A2CYP2C9CYP2C19MMP1MMP2
SCHEMBL3781516 0.75 KMT2A (0.46) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324305-A1 PRODUCTION METHOD OF POLYCYCLIC LACTAMS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-20090118519-A1 Production Method of Polycyclic Lactams SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-07 US disclosed
EP-2014647-A1 PROCESS FOR PRODUCING POLYCYCLIC LACTAM Sumitomo Chemical Company, Limited (JP) 2009-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118519-A1 Production Method of Polycyclic Lactams MRPL21, COASY, ASNS ALDH1A1 1979/4885CYP1A2 53/4885CYP2C9 20/4885
US-20100324305-A1 PRODUCTION METHOD OF POLYCYCLIC LACTAMS COASY, MRPL21, ASNS ALDH1A1 1821/4885CYP1A2 38/4885CYP2C9 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.